179 related articles for article (PubMed ID: 36810118)
1. Clear cell renal cell carcinoma with cystic component similar to multilocular cystic renal neoplasm of low malignant potential: a rare pattern of cyst-dependent progression from multilocular cystic renal neoplasm of low malignant potential.
Yang B; Sun L; Cao WF; Qi LS; Guo YH; Sun Y
Diagn Pathol; 2023 Feb; 18(1):27. PubMed ID: 36810118
[TBL] [Abstract][Full Text] [Related]
2. Xp11 translocation renal cell carcinoma with morphological features mimicking multilocular cystic renal neoplasm of low malignant potential: a series of six cases with molecular analysis.
Song Y; Yin X; Xia Q; Zheng L; Yao J; Zeng H; Nie L; Gong J; Zhou Q; Chen N
J Clin Pathol; 2021 Mar; 74(3):171-176. PubMed ID: 32699116
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic features and differential diagnosis of multilocular cystic renal cell carcinoma].
Zhang W; Li Y; Lu Q; Zhuang J; Wang Q; Zhao H; Yu W; Kang E; Feng Z
Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):723-7. PubMed ID: 25582248
[TBL] [Abstract][Full Text] [Related]
4. Cystic clear cell papillary renal cell carcinoma: is it related to multilocular clear cell cystic neoplasm of low malignant potential?
Brimo F; Atallah C; Li G; Srigley JR
Histopathology; 2016 Apr; 68(5):666-72. PubMed ID: 26256827
[TBL] [Abstract][Full Text] [Related]
5. Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum.
Tretiakova M; Mehta V; Kocherginsky M; Minor A; Shen SS; Sirintrapun SJ; Yao JL; Alvarado-Cabrero I; Antic T; Eggener SE; Picken MM; Paner GP
Virchows Arch; 2018 Jul; 473(1):85-93. PubMed ID: 29770853
[TBL] [Abstract][Full Text] [Related]
6. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
[TBL] [Abstract][Full Text] [Related]
7. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray.
He H; Zhou GX; Zhou M; Chen L
Int J Gynecol Pathol; 2011 Sep; 30(5):425-30. PubMed ID: 21804394
[TBL] [Abstract][Full Text] [Related]
8. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
9. Update on selected renal cell tumors with clear cell features. With emphasis on multilocular cystic clear cell renal cell carcinoma.
Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L
Histol Histopathol; 2013 Dec; 28(12):1555-66. PubMed ID: 23893851
[TBL] [Abstract][Full Text] [Related]
10. Synchronous clear cell renal cell carcinoma and multilocular cystic renal cell neoplasia of low malignant potential: A clinico-pathologic and molecular study.
Raspollini MR; Castiglione F; Cheng L; Montironi R; Lopez-Beltran A
Pathol Res Pract; 2016 May; 212(5):471-4. PubMed ID: 26874573
[TBL] [Abstract][Full Text] [Related]
11. Cystic partially regressed clear cell renal cell carcinoma: a potential mimic of multilocular cystic renal cell carcinoma.
Williamson SR; MacLennan GT; Lopez-Beltran A; Montironi R; Tan PH; Martignoni G; Grignon DJ; Eble JN; Idrees MT; Scarpelli M; Cheng L
Histopathology; 2013 Dec; 63(6):767-79. PubMed ID: 24117777
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological study and immunohistochemical expression of CA9 in cystic multilocular renal cell carcinomas].
Li G; Badin G; Berremila S; Obadia F; Tostain J; Péoc'h M
Prog Urol; 2012 Sep; 22(10):572-6. PubMed ID: 22920335
[TBL] [Abstract][Full Text] [Related]
13. [The incidence of malignant transformation of renal cysts of category 1, 2, and 2F by the BOSNIAK classification into multilocular cystic renal cell carcinoma].
Darenkov SP; Proskokov AA; Agabekian AA; Trofimov IA
Urologiia; 2018 Jul; (3):111-115. PubMed ID: 30035429
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
[No Abstract] [Full Text] [Related]
15. [Acquired cystic kidney disease-associated renal cell carcinoma: a clinicopathologic study of three cases].
Zhang W; Xu LL; Yu WJ; Wang Q; Jiang YX; Liu Y; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):366-371. PubMed ID: 29783804
[No Abstract] [Full Text] [Related]
16. CA9 as a molecular marker for differential diagnosis of cystic renal tumors.
Li G; Bilal I; Gentil-Perret A; Feng G; Zhao A; Peoc'h M; Genin C; Tostain J; Gigante M
Urol Oncol; 2012; 30(4):463-8. PubMed ID: 20822935
[TBL] [Abstract][Full Text] [Related]
17. Papillary pattern in clear cell renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases.
Alaghehbandan R; Ulamec M; Martinek P; Pivovarcikova K; Michalova K; Skenderi F; Hora M; Michal M; Hes O
Ann Diagn Pathol; 2019 Feb; 38():80-86. PubMed ID: 30502717
[TBL] [Abstract][Full Text] [Related]
18. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic features and molecular genetic analysis of multilocular cystic renal cell carcinoma].
Yu YW; Hou JG; Chen HT; Cao GW; Wang LH; Xu CL; Sun YH
Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):721-5. PubMed ID: 19094704
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of CD44, matrix metalloproteinase2 and matrix metalloproteinase9 in renal cell carcinomas.
Lee YM; Kim JM; Lee HJ; Seong IO; Kim KH
Urol Oncol; 2019 Oct; 37(10):742-748. PubMed ID: 31053527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
